Intraocular pressure dynamics with prostaglandin analogs: a clinical application of water-drinking test
Pelin Özyol,1 Erhan Özyol,1 Ercan Baldemir2 1Ophthalmology Department, 2Biostatistics Department, Faculty of Medicine, Mugla Sitki Kocman University, Mugla, Turkey Aim: To evaluate the clinical applicability of the water-drinking test in treatment-naive primary open-angle glaucom...
Guardado en:
Autores principales: | , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/004ca7ff2b5342fe929abf596e8d21ee |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:004ca7ff2b5342fe929abf596e8d21ee |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:004ca7ff2b5342fe929abf596e8d21ee2021-12-02T00:41:23ZIntraocular pressure dynamics with prostaglandin analogs: a clinical application of water-drinking test1177-5483https://doaj.org/article/004ca7ff2b5342fe929abf596e8d21ee2016-07-01T00:00:00Zhttps://www.dovepress.com/intraocular-pressure-dynamics-with-prostaglandin-analogs-a-clinical-ap-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Pelin Özyol,1 Erhan Özyol,1 Ercan Baldemir2 1Ophthalmology Department, 2Biostatistics Department, Faculty of Medicine, Mugla Sitki Kocman University, Mugla, Turkey Aim: To evaluate the clinical applicability of the water-drinking test in treatment-naive primary open-angle glaucoma patients. Methods: Twenty newly diagnosed primary open-angle glaucoma patients and 20 healthy controls were enrolled in this prospective study. The water-drinking test was performed at baseline and 6 weeks and 3 months after prostaglandin analog treatment. Peak and fluctuation of intraocular pressure (IOP) measurements obtained with the water-drinking test during follow-up were analyzed. Analysis of variance for repeated measures and paired and unpaired t-tests were used for statistical analysis. Results: The mean baseline IOP values in patients with primary open-angle glaucoma were 25.1±4.6 mmHg before prostaglandin analog treatment, 19.8±3.7 mmHg at week 6, and 17.9±2.2 mmHg at month 3 after treatment. The difference in mean baseline IOP of the water-drinking tests was statistically significant (P<0.001). At 6 weeks of prostaglandin analog treatment, two patients had high peak and fluctuation of IOP measurements despite a reduction in baseline IOP. After modifying treatment, patients had lower peak and fluctuation of IOP values at month 3 of the study. Conclusion: Peak and fluctuation of IOP in response to the water-drinking test were lower with prostaglandin analogs compared with before medication. The water-drinking test can represent an additional benefit in the management of glaucoma patients, especially by detecting higher peak and fluctuation of IOP values despite a reduced mean IOP. Therefore, it could be helpful as a supplementary method in monitoring IOP in the clinical practice. Keywords: glaucoma, intraocular pressure, water-drinking test, prostaglandin analog, intra­ocular pressure fluctuationÖzyol PÖzyol EBaldemir EDove Medical PressarticleGlaucomaintraocular pressurewater-drinking testprostaglandin analogueintraocular pressure fluctuation.OphthalmologyRE1-994ENClinical Ophthalmology, Vol 2016, Iss Issue 1, Pp 1351-1356 (2016) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Glaucoma intraocular pressure water-drinking test prostaglandin analogue intraocular pressure fluctuation. Ophthalmology RE1-994 |
spellingShingle |
Glaucoma intraocular pressure water-drinking test prostaglandin analogue intraocular pressure fluctuation. Ophthalmology RE1-994 Özyol P Özyol E Baldemir E Intraocular pressure dynamics with prostaglandin analogs: a clinical application of water-drinking test |
description |
Pelin Özyol,1 Erhan Özyol,1 Ercan Baldemir2 1Ophthalmology Department, 2Biostatistics Department, Faculty of Medicine, Mugla Sitki Kocman University, Mugla, Turkey Aim: To evaluate the clinical applicability of the water-drinking test in treatment-naive primary open-angle glaucoma patients. Methods: Twenty newly diagnosed primary open-angle glaucoma patients and 20 healthy controls were enrolled in this prospective study. The water-drinking test was performed at baseline and 6 weeks and 3 months after prostaglandin analog treatment. Peak and fluctuation of intraocular pressure (IOP) measurements obtained with the water-drinking test during follow-up were analyzed. Analysis of variance for repeated measures and paired and unpaired t-tests were used for statistical analysis. Results: The mean baseline IOP values in patients with primary open-angle glaucoma were 25.1±4.6 mmHg before prostaglandin analog treatment, 19.8±3.7 mmHg at week 6, and 17.9±2.2 mmHg at month 3 after treatment. The difference in mean baseline IOP of the water-drinking tests was statistically significant (P<0.001). At 6 weeks of prostaglandin analog treatment, two patients had high peak and fluctuation of IOP measurements despite a reduction in baseline IOP. After modifying treatment, patients had lower peak and fluctuation of IOP values at month 3 of the study. Conclusion: Peak and fluctuation of IOP in response to the water-drinking test were lower with prostaglandin analogs compared with before medication. The water-drinking test can represent an additional benefit in the management of glaucoma patients, especially by detecting higher peak and fluctuation of IOP values despite a reduced mean IOP. Therefore, it could be helpful as a supplementary method in monitoring IOP in the clinical practice. Keywords: glaucoma, intraocular pressure, water-drinking test, prostaglandin analog, intra­ocular pressure fluctuation |
format |
article |
author |
Özyol P Özyol E Baldemir E |
author_facet |
Özyol P Özyol E Baldemir E |
author_sort |
Özyol P |
title |
Intraocular pressure dynamics with prostaglandin analogs: a clinical application of water-drinking test |
title_short |
Intraocular pressure dynamics with prostaglandin analogs: a clinical application of water-drinking test |
title_full |
Intraocular pressure dynamics with prostaglandin analogs: a clinical application of water-drinking test |
title_fullStr |
Intraocular pressure dynamics with prostaglandin analogs: a clinical application of water-drinking test |
title_full_unstemmed |
Intraocular pressure dynamics with prostaglandin analogs: a clinical application of water-drinking test |
title_sort |
intraocular pressure dynamics with prostaglandin analogs: a clinical application of water-drinking test |
publisher |
Dove Medical Press |
publishDate |
2016 |
url |
https://doaj.org/article/004ca7ff2b5342fe929abf596e8d21ee |
work_keys_str_mv |
AT ozyolp intraocularpressuredynamicswithprostaglandinanalogsaclinicalapplicationofwaterdrinkingtest AT ozyole intraocularpressuredynamicswithprostaglandinanalogsaclinicalapplicationofwaterdrinkingtest AT baldemire intraocularpressuredynamicswithprostaglandinanalogsaclinicalapplicationofwaterdrinkingtest |
_version_ |
1718403534165114880 |